<DOC>
	<DOCNO>NCT00036582</DOCNO>
	<brief_summary>The purpose study determine safety effectiveness clozapine child adolescent treatment resistant bipolar disorder . This study also explore brain function early-onset bipolar disorder .</brief_summary>
	<brief_title>Clozapine v . Placebo Treatment-Refractory Bipolar Disorder Children Adolescents</brief_title>
	<detailed_description>Bipolar disorder ( BPD ) child adolescents serious illness carry high risk chronicity , impair comorbidities , complete suicide . Treatment option often limited inefficacy intolerable side effect . Open trial adult bipolar subject several case series child adolescent provide preliminary evidence clozapine , atypical antipsychotic , may effective treatment-resistant bipolar disorder . The first specific aim study test efficacy safety clozapine compare placebo double-blind study child adolescent treatment refractory BPD . Other specific aim involve explore pathophysiology early-onset BPD 1 ) testing hypothesis , compare control , child BPD increase psychophysiological reactivity emotional stimulus decrease prepulse inhibition ; 2 ) obtain sample genetic material affect probands parent later analysis ; 3 ) identify anatomic change brain child BPD use structural MRI .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<criteria>INCLUSION CRITERIA ( All 5 must meet ) : Children BPD Ages 817 Currently meet criteria bipolar disorder , manic mixed , determine KSADS diagnostic interview . Treatmentresistant , define history unsuccessful trial lithium ( document level great 0.8 mEq/L ) , valproic acid ( document level great 50 ug/ml ) , carbamazepine ( document level great equal 6 ug/ml ) , neuroleptic well combination two agent . Each trial must least 6 week long . A trial consider unsuccessful medication discontinue intolerable sideeffects . The child treatment community psychiatrist return upon completion study . Current CGAS score le 50 EXCLUSION CRITERIA : Children BPD Full scale IQ le 80 Meets criteria substance use disorder three month prior randomization Currently pregnant , lactate , sexually active without use barrier method contraception Previous treatment clozapine History seizures History leukopenia agranulocytosis Presence unstable medical illness INCLUSION CRITERIA : CONTROLS Control subject age sex match BPD subject . They normal physical neurological examination , identify primary care physician . Both control subject firstdegree relative must free current past psychopathology . EXCLUSION CRITERIA : CONTROLS I.Q le 80 ; ongoing medical illness ; neurologic disorder ( include seizure ) ; pregnancy ; meeting past present criterion diagnosis KSADSPL ; meet criterion A posttraumatic stress disorder ( exposure traumatic event ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2004</verification_date>
	<keyword>Psychophysiology</keyword>
	<keyword>Structural MRI</keyword>
	<keyword>Genetics</keyword>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Children Adolescents</keyword>
	<keyword>Clozapine</keyword>
	<keyword>Placebo</keyword>
	<keyword>Treatment-Refractory</keyword>
	<keyword>Bipolar</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>HV</keyword>
	<keyword>BPD</keyword>
	<keyword>Normal Control</keyword>
</DOC>